Rockwell Medical RMTI
NASDAQ RMTI
$7.95 -0.11 (-1.30%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2012 - 2026)

Rockwell Medical's (RMTI) quarterly Change in Acquisitions & Divestments came in at $7.2 million in Q2 2026, up 140.0% on a YoY basis from $3.0 million in Q2 2025, and little changed quarter-over-quarter from $7.2 million in Q1 2026.

Analysis

Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2012 - 2026) Analysis & Trends

Rockwell Medical (RMTI) has reported Change in Acquisitions & Divestments for 12 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Acquisitions & Divestments rose 140.0% year-over-year to $7.2 million; the trailing twelve-month figure through Jun 2026 stood at $24.6 million (up 310.0% YoY), and the FY2025 full-year result was $16.2 million, up 708.79% from the prior year.
  • Change in Acquisitions & Divestments steadied at $7.2 million in Q2 2026 per RMTI's latest filing, from $7.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $12.0 million in Q1 2022 and bottomed at $1.8 million in Q2 2023.
  • Historically, Change in Acquisitions & Divestments has averaged $5.2 million across 5 years, with a median of $4.0 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments sank 44.52% in 2023, then surged 140.0% in 2026.
  • Over 5 years, Change in Acquisitions & Divestments stood at $7.2 million in 2022, then tumbled by 44.52% to $4.0 million in 2023, then slumped by 49.92% to $2.0 million in 2024, then soared by 259.46% to $7.2 million in 2025, then changed by 0.0% to $7.2 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $7.2 million, $7.2 million, and $7.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00
9 United Health Products 9.09 Mn 9.06 Mn -
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.20 Mn
Mar 31, 2026 7.20 Mn
Dec 31, 2025 7.20 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 3.00 Mn
Jun 30, 2024 2.00 Mn
Dec 31, 2023 4.00 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 7.50 Mn
Dec 31, 2022 7.21 Mn
Mar 31, 2022 11.97 Mn
Dec 31, 2021 7.61 Mn
Sep 30, 2021 4.11 Mn
Jun 30, 2021 8.44 Mn
Mar 31, 2021 6.74 Mn
Dec 31, 2020 6.49 Mn
Sep 30, 2020 9.58 Mn
Jun 30, 2020 5.84 Mn